Fatigue, pain, and depression in pre-autotransplant breast cancer patients

被引:116
作者
Gaston-Johansson, F
Fall-Dickson, JM
Bakos, AB
Kennedy, MJ
机构
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Int Program, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Extramural Program, Baltimore, MD 21205 USA
[4] Univ Dublin Trinity Coll, St James Hosp, Dept Hematol & Oncol, Dublin 2, Ireland
关键词
adjuvant chemotherapy; breast cancer; depression; fatigue; health status; pain;
D O I
10.1046/j.1523-5394.1999.75008.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVES: The purpose of this study was to determine the influence of fatigue, pain, and depression on health status in breast cancer patients who had completed adjuvant chemotherapy and mere scheduled for autologous bone marrow/peripheral blood stem cell transplant (AT). MATERIALS AND METHODS: A predictive, correlational design was used, ii convenience sample of 127 women with stages II, III, and TV breast cancer was recruited. The setting was an urban National Cancer Institute-designated comprehensive cancer center located in the Eastern United States. Standardized questionnaires and the Gaston-Johansson Painometer (POM) were used to measure the variables. The subjects completed questionnaires in the outpatient clinic. Relationships between een the multiple dimensions of fatigue and pain, depression, and health status mere examined. Hierarchical regression techniques mere used to determine the valance in health status accounted for by fatigue, pain, and depression. RESULTS: The subjects were age 22 to 60 years (Mean = 45; SD = 7.6), and primarily were married, white, Protestant, college educated, employed in a professional position, and had an average yearly household income of equal to or greater than $50,000. All subjects had previously received surgery and chemotherapy. Ninety-one percent of the participants reported fatigue as measured by the Fatigue Visual Analogue Scale. Forti-seven percent of the participants reported pain as measured by the Gaston-Johansson POM visual analogue scale. Fifty-four percent of die participants reported depression, ranging from mild to severe/high. Subjects reported a mean total perceived health status rating of 50.73 (SD 10.79). Fatigue, pain, and depression were all significantly correlated to each other and to total health status. Depression (P < .001) and pain (P < .01) significantly accounted for 64% (adjusted R-2 = .60) of the variance in total health status. Fatigue (P < .05) and depression (P < .001) accounted for 42% (adjusted R-2 = .36) of the variance in the perception of health status. CONCLUSIONS: Women with breast cancer previously treated with chemotherapy;ind awaiting AT may experience fatigue, pain, depression, and alterations in health status. Pain and depression had a significant impact on a woman's total health status, whereas depression and fatigue had an influence on perceived health status. Of the different dimensions of health status, one's perceptions of health status had the strongest correlation to total health status (r = .84, P < .001). Healthcare professionals need to be aware of the effects of multiple symptoms on health status and to provide appropriate care to alleviate them.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 41 条
[1]   Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital [J].
Aass, N ;
Fossa, SD ;
Dahl, AA ;
Moe, TJ .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) :1597-1604
[2]  
Aistars J, 1987, Oncol Nurs Forum, V14, P25
[3]  
[Anonymous], CANC EXPERIENCE NURS
[4]   High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America [J].
Antman, KH ;
Rowlings, PA ;
Vaughan, WP ;
Pelz, CJ ;
Fay, JW ;
Fields, KK ;
Freytes, CO ;
Gale, RP ;
Hillner, BE ;
Holland, HK ;
Kennedy, MJ ;
Klein, JP ;
Lazarus, HM ;
McCarthy, PL ;
Saez, R ;
Spitzer, G ;
Stadtmauer, EA ;
Williams, SF ;
Wolff, S ;
Sobocinski, KA ;
Armitage, JO ;
Horowitz, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1870-1879
[5]  
Arathuzik M D, 1991, West J Nurs Res, V13, P714, DOI 10.1177/019394599101300604
[6]  
Baron R H, 1998, Clin J Oncol Nurs, V2, P17
[7]  
Beck A.T., 1993, BECK DEPRESSION INVE
[8]   LATE EFFECTS OF ADJUVANT CHEMOTHERAPY AND POSTOPERATIVE RADIOTHERAPY ON QUALITY-OF-LIFE AMONG BREAST-CANCER PATIENTS [J].
BERGLUND, G ;
BOLUND, C ;
FORNANDER, T ;
RUTQVIST, LE ;
SJODEN, PO .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (09) :1075-1081
[9]  
Blesch K S, 1991, Oncol Nurs Forum, V18, P81
[10]  
Chielens D, 1990, Oncol Nurs Forum, V17, P857